Sernova Corp. announced it has entered into a preclinical research collaboration with AstraZeneca to evaluate the use of Sernova's Cell Pouch SystemT in combination with AstraZeneca's novel therapeutic cells. AstraZeneca is exploring the use of Sernova' Cell Pouch System as a potential platform for integration with its development of the next wave of innovative cell therapies for various indications.

Under the terms of the collaboration, AstraZeneca will lead and completely fund the development of the cell technologies and pre-clinical activities in conjunction with Sernova. The discovery work is being funded and conducted at AstraZeneca. The preclinical research outcomes will determine the feasibility of potential therapeutic applications and subsequent product development activities between the two companies.